Looking forward to the scoping study results, but disappointed with the fact that any share price increase will be dampened by the impending capital raise ($800,000 left in the coffers come December Qtr). Terrible timing and they could've raised more in the last capital raise when sentiment was better...
Don't expect any miracles on Friday, even if the results beat expectations.